PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
05-Sep-2023 IQVIA CFO Ron Bruehlman to Speak at Baird Global Healthcare Conference on September 13, 2023 Businesswire
05-Sep-2023 Safe & Green Holdings Corp. Announces the Appointment of Jill Anderson to the Company’s Board of Directors Businesswire
05-Sep-2023 Procaps Group Reports Second Quarter 2023 Results Businesswire
05-Sep-2023 Revolutionizing Glaucoma Management: Emerging Therapies Projected to Drive Global Market to 2032 - ResearchAndMarkets.com Businesswire
05-Sep-2023 Revvity Unveils Several Next-Generation Preclinical Imaging Technologies to Help Scientists Drive Breakthrough Discoveries Businesswire
05-Sep-2023 PsychoGenics and Collaborations Pharmaceuticals awarded a $1M grant to use AI platforms to design new drugs for mental health disorders Businesswire
05-Sep-2023 IPA Announces Board Refreshment Businesswire
05-Sep-2023 Long-Term Follow-up Data on Sustained Immunogenicity and Safety for GARDASIL®9 Published in Pediatrics Businesswire
05-Sep-2023 Enveric Biosciences Announces New U.S. Patent for C4-Carboxylic Acid-Substituted Tryptamine Derivatives Businesswire
05-Sep-2023 OmniAb to Participate in Two Investor Conferences in September Businesswire
05-Sep-2023 Glyscend Therapeutics Appoints Sapan A. Shah, Ph.D., Accomplished Industry Executive, as Chief Executive Officer Businesswire
05-Sep-2023 Armis Appoints Alex Mosher to Chief Revenue Officer Businesswire
05-Sep-2023 Applied Industrial Technologies Acquires Bearing Distributors and Cangro Industries Businesswire
05-Sep-2023 Cybin Announces Grant of U.S. Patent Covering Deuterated Tryptamines Businesswire
05-Sep-2023 GlycoMimetics to Participate in Upcoming H.C. Wainwright 25th Annual Global Investment Conference Businesswire
05-Sep-2023 Star Therapeutics Raises $90 Million Financing to Accelerate Its Pipeline of Novel Antibody Therapies and Growth of Its Portfolio Companies Businesswire
05-Sep-2023 Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference Businesswire
05-Sep-2023 Stoke Therapeutics Presents Data Related to the Ongoing Clinical Development of STK-001 for the Treatment of Dravet Syndrome at the 35th International Epilepsy Congress Businesswire
05-Sep-2023 FDA Grants Xenex Authorization for LightStrike+ UV Robot via De Novo – First & Only Microbial Reduction Robot for Healthcare Facilities Businesswire
05-Sep-2023 Merck to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference Businesswire